Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma

Cerchione, C; Ferrara, K; Peluso, I; Di Perna, M; Nappi, D; Pareto, AE; Pane, F; Catalano, L

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018; 18 (): S255